The tumor microenvironment plays a crucial role in tumor development and progression. Tumors alter the topography and molecular composition of stromal extracellular matrix (ECM) by regulation of fibroblastic stromal cells during tumor development. These physical and biochemical alterations of the stroma affect the properties of naive stromal cells to become activated and fuel stromal activation thus promoting cancer cell progression. The vital interplay between tumor and stroma means that, in principle, it is possible to target signaling pathways that regulate tumor-induced stroma activation and thereby contain tumorigenesis. We have developed 3D in vitro and an ex vivo systems comprising cells plated in 3D in matrices derived from stromal fibroblasts or in decellularized tumorigenic tissue ECMs. Using these systems, we have not only observed that stromal matrices are modified as the tumor develops but that tumor matrices are both necessary and sufficient to induce normal fibroblasts to display properties characteristic of tumor-associated fibroblasts. In the past we showed that alterations in integrin-dependent signaling pathways are critical to the development of tumor-promoting stroma and that tumor cell invasion can be repressed by targeting fundamental stroma components. In collaboration with a team of clinical researchers focused on kidney cancer, we have developed extensive resources to dissect stromal-tumor interactions in this disease. Preliminary results rendered: a proteomic signature that has defined a group of proteins including lysyl oxidase (LOX), and periostin as specifically upregulated in tumor-associated ECM, and identified palladin stromal expression as highly predictive of tumor prognosis in renal cancer. In this study we propose to: 1. Test the hypothesis that specific structural and biochemical components of the tumor-associated ECM collaborate to induce a phenotypic switch in naive fibroblasts. 2. Establish the role for palladin in the phenotypic switch regulated by specific integrin crosstalk induced by tumor-associated but not normal ECM. 3. Assess the clinical importance of stromal activation in human renal cell carcinoma (RCC).

Public Health Relevance

Results stemming from this study will facilitate uncovering some of the mechanisms responsible for the tumor fueling vicious cycle which maintains stroma activation and in turn incites tumor progression. The study will emphasize the clinical relevance of assessing the progression of mesenchymal stroma, and it could reveal possible targets to prevent stroma progression and consequently stall tumorigenesis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA113451-06A1
Application #
8292558
Study Section
Tumor Microenvironment Study Section (TME)
Program Officer
Mohla, Suresh
Project Start
2005-04-01
Project End
2017-03-31
Budget Start
2012-04-12
Budget End
2013-03-31
Support Year
6
Fiscal Year
2012
Total Cost
$245,775
Indirect Cost
$107,893
Name
Research Institute of Fox Chase Cancer Center
Department
Type
DUNS #
064367329
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Bassi, Daniel E; Cenna, Jonathan; Zhang, Jirong et al. (2015) Enhanced aggressiveness of benzopyrene-induced squamous carcinomas in transgenic mice overexpressing the proprotein convertase PACE4 (PCSK6). Mol Carcinog 54:1122-31
Hakanson, Maria; Cukierman, Edna; Charnley, Mirren (2014) Miniaturized pre-clinical cancer models as research and diagnostic tools. Adv Drug Deliv Rev 69-70:52-66
Chang, Yu-Chung; Zhang, Hao; Franco-Barraza, Janusz et al. (2014) Structural and mechanistic insights into the recruitment of talin by RIAM in integrin signaling. Structure 22:1810-20
Campbell, Catherine B; Cukierman, Edna; Artym, Vira V (2014) 3-D extracellular matrix from sectioned human tissues. Curr Protoc Cell Biol 62:Unit 19.16.1-20
Rybinski, Brad; Franco-Barraza, Janusz; Cukierman, Edna (2014) The wound healing, chronic fibrosis, and cancer progression triad. Physiol Genomics 46:223-44
Hutmacher, Dietmar W; Cukierman, Edna (2014) Engineering of tumor microenvironments. Adv Drug Deliv Rev 79-80:1-2
Kwon, Youngjoo; Cukierman, Edna; Godwin, Andrew K (2011) Differential expressions of adhesive molecules and proteases define mechanisms of ovarian tumor cell matrix penetration/invasion. PLoS One 6:e18872
Gupta, Vivekanand; Bassi, Daniel E; Simons, Jeffrey D et al. (2011) Elevated expression of stromal palladin predicts poor clinical outcome in renal cell carcinoma. PLoS One 6:e21494
Lee, Hyung-Ok; Mullins, Stefanie R; Franco-Barraza, Janusz et al. (2011) FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells. BMC Cancer 11:245
Shatalova, Ekaterina G; Klein-Szanto, Andres J P; Devarajan, Karthik et al. (2011) Estrogen and cytochrome P450 1B1 contribute to both early- and late-stage head and neck carcinogenesis. Cancer Prev Res (Phila) 4:107-15

Showing the most recent 10 out of 16 publications